Menu Search
Equities

Futura Medical PLC

GYX:DUS

Futura Medical PLC

Actions
  • Price (EUR)0.41
  • Today's Change0.000 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 18:32 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Futura Medical PLC had net income fall 11.40% from a loss of 5.85m to a larger loss of 6.51m despite a -- increase in revenues from 0.00 to 3.10m.
Gross margin67.70%
Net profit margin-44.68%
Operating margin-49.83%
Return on assets-38.14%
Return on equity-47.43%
Return on investment-47.43%
More ▼

Cash flow in GBPView more

In 2023, Futura Medical PLC increased its cash reserves by 91.60%, or 3.69m. Cash Flow from Financing totalled 4.55m or 146.72% of revenues. In addition the company generated 570.25k in cash from operations while cash used for investing totalled 1.43m.
Cash flow per share-0.0117
Price/Cash flow per share--
Book value per share0.0259
Tangible book value per share0.0259
More ▼

Balance sheet in GBPView more

Futura Medical PLC has little financial risk as the capital structure does not rely on leverage.
Current ratio3.75
Quick ratio3.75
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.